Institut universitaire de cardiologie et de pneumologie de Quebec, Université Laval, Québec, Québec, Canada.
Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Open Heart. 2022 Dec;9(2). doi: 10.1136/openhrt-2022-002139.
There are significant sex differences in the prevalence and severity of cardiac calcifying processes. Women harbour more severe mitral annular calcification (MAC), while men exhibit worse aortic valve (AVC) and coronary artery (CAC) calcification. To better understand these differences, we investigated the correlates of cardiac calcification according to sex.
We conducted a cross-sectional study of 406 patients with ≥mild aortic stenosis (AS) defined by an aortic valve area ≤1.5 cm, a peak aortic jet velocity >2.0 m/s, or a mean transvalvular gradient >15 mm Hg. Doppler-echocardiography and non-contrast multidetector CT were performed concomitantly to assess AS and cardiac calcifications.
Mean age was 71±11 years and 33% were women. The AS haemodynamics were not significantly different between sexes (all p>0.50), with a mean indexed aortic valve area of 0.59±0.21 cm/m, peak aortic jet velocity of 2.78 (2.37-3.68) m/s, and mean gradient of 17.9 (12.8-31.3) mm Hg for the whole cohort. Compared with men, women harboured lower AVC (480 (222-1191) vs 1003 (484-2329) Agatston unit, AU; p<0.0001) and CAC (366 (50-914) vs 618 (167-1357) AU; p=0.007), but more severe MAC (60 (1-887) vs 48 (0-351) AU; p=0.08) and ascending aorta calcification (227 (43-863) vs 142 (7-493) AU; p=0.03). After comprehensive adjustment, sex remained an independent predictor of each cardiac calcification subtype (all p<0.02) except for the ascending aorta (p=0.32). In multivariable analysis, certain variables, like age or bicuspid aortic valve, were associated with the calcification scores in both sexes. Sex-specific predictors of calcification burden were absence of angiotensin receptor blockers (β=-0.26; p=0.007) and renal impairment (β=0.26; p=0.003) for AVC, and bisphosphonates (β=0.20; p=0.05) for CAC in women; coronary artery disease (β=0.25; p=0.001) for AVC, and angiotensin receptor blockers (β=0.19; p=0.02) and calcium/vitamin D (β=0.15; p=0.02) for MAC in men.
In AS, factors associated with cardiac valvular and arterial calcification differ between sexes, suggesting an important contributory role of sex in the pathophysiology of these calcifying processes.
心脏钙化过程的发生率和严重程度存在显著的性别差异。女性更容易出现严重的二尖瓣环钙化(MAC),而男性则表现出更严重的主动脉瓣(AVC)和冠状动脉(CAC)钙化。为了更好地理解这些差异,我们根据性别研究了心脏钙化的相关因素。
我们对 406 名≥轻度主动脉瓣狭窄(AS)患者进行了横断面研究,这些患者的定义为主动脉瓣面积≤1.5cm²,峰值主动脉射流速度>2.0m/s 或平均跨瓣梯度>15mmHg。同时进行多普勒超声心动图和非对比多层 CT 检查以评估 AS 和心脏钙化。
平均年龄为 71±11 岁,33%为女性。AS 的血流动力学在性别之间无显著差异(均 p>0.50),整个队列的平均指数化主动脉瓣面积为 0.59±0.21cm²/m²,峰值主动脉射流速度为 2.78(2.37-3.68)m/s,平均梯度为 17.9(12.8-31.3)mmHg。与男性相比,女性的 AVC(480(222-1191)vs 1003(484-2329)Agatston 单位,AU;p<0.0001)和 CAC(366(50-914)vs 618(167-1357)AU;p=0.007)较低,但 MAC(60(1-887)vs 48(0-351)AU;p=0.08)和升主动脉钙化(227(43-863)vs 142(7-493)AU;p=0.03)更严重。经过全面调整,性别仍然是每种心脏钙化亚型的独立预测因素(均 p<0.02),除了升主动脉(p=0.32)。在多变量分析中,某些变量,如年龄或二叶式主动脉瓣,与两性的钙化评分相关。女性 AVC 钙化负担的性别特异性预测因素为无血管紧张素受体阻滞剂(β=-0.26;p=0.007)和肾功能不全(β=-0.26;p=0.003),而 CAC 则为双膦酸盐(β=0.20;p=0.05);女性的 AVC 为冠心病(β=0.25;p=0.001),而男性的 AVC 为血管紧张素受体阻滞剂(β=0.19;p=0.02)和钙/维生素 D(β=0.15;p=0.02)。
在 AS 中,与心脏瓣膜和动脉钙化相关的因素在性别之间存在差异,这表明性别在这些钙化过程的病理生理学中起着重要的作用。